Thank you, Mr. Chair. Thank you again for the few minutes.
I only have four, so you're almost out of here.
There is funding for subatomic and—my friend Mr. Garneau would like this—there is life science funding for a facility that is already funded. I want to know what the level of funding is, how long it has been around, how long we've been funding it, and what we are expecting to achieve at Industry from funding this facility.